Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-26T07:59:23.037Z Has data issue: false hasContentIssue false
  • English
  • Français

Tardive Dyskinesia and Depot Fluphenazine

Published online by Cambridge University Press:  29 January 2018

Henry A. Nasrallah
Henry A. Nasrallah*
Affiliation:
Department of Psychiatry, University of California, San Diego, La Jolla, California 92093, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 134 , Issue 5 , May 1979 , pp. 550
Copyright
Copyright © Royal College of Psychiatrists, 1979 

References

Chouinard, G., Annable, L. & Chouinard, A. R. (1977) Factors related to tardive dyskinesia. Proceedings of the 130th Annual Meeting of the American Psychiatric Association, page 52.Google Scholar
Gardos, G., Cole, J. O. & La Brie, R. E. (1977) Drug variables in the etiology of tardive dyskinesia—discriminate function analysis. Progress in Neuro-psychopharmacology, 1, 147–54.Google Scholar
Jeste, D. V., Oligiati, S. G. & Ghali, A. Y. (1977) Masking of tardive dyskinesia with four times a day administration of chlorpromazine. Diseases of the Nervous System, 38, 755–8.Google Scholar
Nasrallah, H. A., Rivera-Calimlim, L., Rogol, A., Gillen, J. C. & Wyatt, R. J. (1978) Fluphenazine decanoate: plasma concentrations and clinical response. Psychopharmacology Bulletin, 14, 46–7.Google Scholar
Smith, R. C., Strizich, M. & Klass, D. (1978) Drug history and tardive dyskinesia. American Journal of Psychiatry, 135, 1402–3.Google ScholarPubMed
Tarsy, D. & Baldessarini, R. J. (1974) Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology, 13, 927–40.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.